AGR2、Lgr5在结直肠癌中的表达及其临床意义  被引量:11

Expression and its clinical significance of AGR2 and Lgr5 in colorectal cancer

在线阅读下载全文

作  者:刘丽娜[1] 殷云勤[1] 张兆美 席玉[1] 

机构地区:[1]山西医科大学第一医院消化内科,山西太原030001

出  处:《中国现代医生》2014年第14期8-11,15,F0003,共6页China Modern Doctor

摘  要:目的探讨AGR2和Lgr5在人CRC中表达及其与临床病理特征的关系,评价二者联合检测对CRC诊断的意义。方法采用免疫组化SABC法检测70例CRC组织和20例癌旁正常组织中AGR2和Lgr5的表达情况。结果①CRC组织中AGR2阳性表达率较癌旁正常组织显著性增高(68.57%、25.00%,P﹤0.01)。在CRC组织中,AGR2的阳性表达率与肿瘤分化程度与淋巴结转移呈显著相关(P﹤0.05)。②CRC组织中Lgr5阳性表达率较癌旁正常组织显著性增高(74.29%、40.00%,P﹤0.01)。在CRC组织中,Lgr5的阳性表达率与肿瘤分化程度、浸润深度和淋巴结转移有显著相关性(P﹤0.05)。③联合检测AGR2、Lgr5曲线下面积与单独检测比较,差异有统计学意义(P均﹤0.05)。结论 AGR2、Lgr5在CRC的发生、发展过程中发挥了重要作用,两者联合检测有助于对CRC患者肿瘤进展的判断,为CRC患者的分子诊断和治疗提供了理论支持。Objective To investigate the expression and clinical significance of AGR2 and Lgr5 in CRC and the corre-lation with clinical pathologic features. To evaluate the significance with combined detection of the clinical and patho-logical diagnosis of CRC. Methods AGR2 and Lgr5 expression were assessed in 70 cases of CRC and 20 cases of nor-mal tissues near the cancer by immunohistochemistry. Results ①The expression of AGR2 was significantly higher in CRC than that in normal tissue(68.57%vs 25.00%,P〈0.01). The AGR2 expression in CRC was correlated with the de-gree of tumor differentiation and lymph node metastasis(P〈0.05).②The expression of Lgr5 was significantly higher in CRC than that in normal tissue (74.29%vs 40.00%, P〈0.01). The Lgr5 expression in CRC was correlated with the de-gree of tumor differentiation﹑depth of invasion and lymph node metastasis(P〈0.05). ③The Area Under Curve(AUC) of combined detection of AGR2 and Lgr5 were significantly higher than detection of both alone. the difference was statis-tically significant (P all 〈0.05). Conclusion AGR2 and Lgr5 played an important role in the occurrence and develop-ment of CRC, the combined detection not only contribute to the judgment of tumor progression, but also provide theo-retical support for molecular diagnosis and treatment of patients with CRC .

关 键 词:结直肠肿瘤 AGR2 LGR5 免疫组织化学 AGR2 LGR5 

分 类 号:R735.3[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象